Ellington Management Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,814
| Closed | -$509K | – | 836 |
|
|
2017
Q2 | $509K | Buy |
+11,814
| New | +$509K | 0.07% | 224 |
|
|
2015
Q2 | – | Sell |
-44,500
| Closed | -$538K | – | 870 |
|
|
2015
Q1 | $538K | Sell |
44,500
-16,900
| -28% | -$204K | 0.11% | 257 |
|
|
2014
Q4 | $510K | Buy |
61,400
+46,200
| +304% | +$384K | 0.17% | 196 |
|
|
2014
Q3 | $132K | Buy |
+15,200
| New | +$132K | 0.09% | 253 |
|